BioSpace News Archive

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

The pharmaceutical and healthcare sector has witnessed drastic changes in the recent years primarily due to growing prevalence of diseases, technological advancements in medicine, and increasing investments in research and development activities.

The report further provides details about each segments and regions covered in the global Soft Tissue Sarcoma Treatment market. The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

The industry analysis report is considered a valuable source of information about the global Thawing System industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Cytokinetics, Incorporated announced that it is scheduled to report fourth quarter results on February 24, 2022 at 4:00 PM Eastern Time.

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced that Arthur T. Sands, M.D., Ph.D., Nurix’s president and chief executive officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference.

GBS Inc., a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point-of-care, announced its financial results for the second quarter ended December 31, 2021 and provided a recent business update.

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and 12 months ended December 31, 2021.

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company is scheduled to participate in the 11th Annual SVB Leerink Global Healthcare Conference. Company executives will participate in a virtual fireside chat hosted by SVB Leerink.

Beyond Air, Inc. announced financial results for its third fiscal quarter ended December 31, 2021.